These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3503109)

  • 41. Effects of adrenergic drugs on aqueous cAMP and cGMP and intraocular pressure.
    Rowland JM; Potter DE
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979; 212(2):65-75. PubMed ID: 44821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of aminotetralins on intraocular pressure and pupillary function in rabbits.
    Burke JA; Chang FW; Potter DE
    J Auton Pharmacol; 1984 Sep; 4(3):185-92. PubMed ID: 6490680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bronchospasmolytic and cardiovascular effects in anaesthetized cats of ibuterol and terbutaline given intravenously and after inhalation: drug and prodrug compared.
    Andersson P
    Acta Pharmacol Toxicol (Copenh); 1976 Aug; 39(2):225-31. PubMed ID: 947299
    [No Abstract]   [Full Text] [Related]  

  • 44. [The experimental studies of the effect of Forskolin on the lowering of intraocular pressure].
    Peng T; Chen X; Zhou W; Zeng S; Shen B; Wen L; Hu B; Liu C; Yao W
    Yan Ke Xue Bao; 1992 Dec; 8(4):152-5. PubMed ID: 1306493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aporphine derivatives affect ocular function in diverse ways.
    Burke JA; Potter DE
    Curr Eye Res; 1987 Oct; 6(10):1227-36. PubMed ID: 3677783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent.
    Chu TC; He Q; Potter DE
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):507-14. PubMed ID: 12537677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.
    Kanno M; Araie M; Koibuchi H; Masuda K
    Br J Ophthalmol; 2000 Mar; 84(3):293-9. PubMed ID: 10684841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator.
    Burstein NL; Sears ML; Mead A
    Exp Eye Res; 1984 Dec; 39(6):745-9. PubMed ID: 6542866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of ocular hypertension induced by adenosine agonists.
    Crosson CE; Gray T
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1833-9. PubMed ID: 8759351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of oxymetazoline on aqueous humor dynamics and ocular blood flow in monkeys and rabbits.
    Wang RF; Lee PY; Taniguchi T; Becker B; Podos SM; Serle JB; Mittag TW
    Arch Ophthalmol; 1993 Apr; 111(4):535-8. PubMed ID: 8470989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of VIP- and terbutaline stimulated aqueous humor flow by increased intraocular pressure in the cynomolgus monkey.
    Mäepea O; Nilsson SF
    Curr Eye Res; 1991 Aug; 10(8):703-12. PubMed ID: 1914504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cianergoline lowers intraocular pressure in rabbits and monkeys and inhibits contraction of the cat nictitans by suppressing sympathetic neuronal function.
    Potter DE; Shumate DJ
    J Ocul Pharmacol; 1987; 3(4):309-21. PubMed ID: 3503920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of D-timolol on intraocular pressure (IOP), beta blocking activity, and the dynamic changes of drug concentrations in aqueous humor.
    Zhao F; Ji XC; Zheng YZ
    J Ocul Pharmacol; 1989; 5(4):271-9. PubMed ID: 2576432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paradoxical effect of phentolamine on aqueous flow in the rabbit.
    Kiel JW; Reitsamer HA
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):21-6. PubMed ID: 17341146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of IBMX-enhanced ocular hypotension after adrenergic agonists in the rabbit eye.
    Busch MJ; Hoyng PF
    Graefes Arch Clin Exp Ophthalmol; 1995 May; 233(5):296-301. PubMed ID: 7542619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
    Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
    Biol Pharm Bull; 2008 Aug; 31(8):1590-5. PubMed ID: 18670094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experimental studies with timolol: a new ocular hypotensive agent (author's transl)].
    Vareilles P; Schmitt C; Lotti VJ; Le Douarec JC
    J Fr Ophtalmol; 1978 Dec; 1(12):717-21. PubMed ID: 155095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The physiological disposition of ibuterol, terbutaline and isoproterenol after endotracheal instillation to rats.
    Ryrfeldt A; Bodin NO
    Xenobiotica; 1975 Sep; 5(9):521-9. PubMed ID: 1189465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular hypertensive response to beta-adrenoceptor agonists.
    Potter DE; Nicholson HT; Rowland JM
    Curr Eye Res; 1982-1983; 2(10):711-9. PubMed ID: 6137324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys.
    Wang RF; Gagliuso DJ; Podos SM
    J Glaucoma; 2008; 17(1):73-8. PubMed ID: 18303390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.